Completed trials

A Phase 1b/2 study of docetaxel with or without buparlisib as second line therapy for patients with advanced or metastatic squamous non-small cell lung cancer

Cancer type: Lung cancer

Phase: I/II

Principal Investigator: Tell Roger

Country: SE

Keywords: Sweden, 2013-000833-11, Basalt-3

Status: Completed